-+undefined NaN%
-+undefined NaN%
-+undefined NaN%

EF Hutton Adjusts Fate Therapeutics' Price Target to $10 From $16, Keeps Buy Rating

EF Hutton Adjusts Fate Therapeutics' Price Target to $10 From $16, Keeps Buy Rating

MT Newswires · 01/06/2023 05:38